Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | 15.3x - 16.9x | 16.1x |
| Selected Fwd P/E Multiple | 19.0x - 20.9x | 19.9x |
| Fair Value | ₩5,818 - ₩6,431 | ₩6,125 |
| Upside | -0.7% - 9.7% | 4.5% |
| Benchmarks | - | Full Ticker |
| BCWORLD PHARM. Co., Ltd. | - | KOSDAQ:A200780 |
| Kukje Pharma Co., Ltd. | - | KOSE:A002720 |
| Ahn-Gook Pharmaceutical Co., Ltd. | - | KOSDAQ:A001540 |
| Kyung Dong Pharmaceutical Co., Ltd. | - | KOSDAQ:A011040 |
| Sam-A Pharm. Co., Ltd | - | KOSDAQ:A009300 |
| Sinsin Pharmaceutical Co., Ltd | - | KOSDAQ:A002800 |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| A200780 | A002720 | A001540 | A011040 | A009300 | A002800 | |||
| KOSDAQ:A200780 | KOSE:A002720 | KOSDAQ:A001540 | KOSDAQ:A011040 | KOSDAQ:A009300 | KOSDAQ:A002800 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | NM- | 46.0% | -22.9% | 16.7% | 18.0% | ||
| 3Y CAGR | NM- | NM- | 62.3% | -24.4% | 86.7% | NM- | ||
| Latest Twelve Months | -674.5% | 166.3% | 97.2% | 130.7% | -20.6% | 28.0% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | -3.2% | -0.1% | 2.4% | 2.8% | 13.2% | 2.4% | ||
| Prior Fiscal Year | 3.5% | -6.2% | 0.6% | -12.7% | 22.0% | 4.6% | ||
| Latest Fiscal Year | -5.9% | 3.3% | 6.2% | 2.8% | 23.1% | 4.6% | ||
| Latest Twelve Months | -6.6% | 2.7% | 4.5% | 3.0% | 21.1% | 5.2% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 13.1x | 12.9x | 5.9x | 9.7x | 1.4x | 10.6x | ||
| Price / LTM Sales | 0.6x | 0.6x | 0.3x | 0.8x | 1.2x | 0.8x | ||
| LTM P/E Ratio | -8.5x | 22.8x | 7.0x | 27.6x | 5.7x | 16.1x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -8.5x | 7.0x | 27.6x | |||||
| Historical LTM P/E Ratio | -34.4x | 19.8x | 81.8x | |||||
| Selected P/E Multiple | 15.3x | 16.1x | 16.9x | |||||
| (x) LTM Net Income | 5,524 | 5,524 | 5,524 | |||||
| (=) Equity Value | 84,607 | 89,060 | 93,513 | |||||
| (/) Shares Outstanding | 15.2 | 15.2 | 15.2 | |||||
| Implied Value Range | 5,577.06 | 5,870.58 | 6,164.11 | |||||
| FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 5,577.06 | 5,870.58 | 6,164.11 | 5,860.00 | ||||
| Upside / (Downside) | -4.8% | 0.2% | 5.2% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | A200780 | A002720 | A001540 | A011040 | A009300 | A002800 | |
| Value of Common Equity | 41,724 | 98,351 | 88,991 | 160,304 | 107,663 | 88,899 | |
| (/) Shares Outstanding | 9.3 | 20.4 | 11.4 | 26.9 | 6.1 | 15.2 | |
| Implied Stock Price | 4,495.00 | 4,830.00 | 7,830.00 | 5,950.00 | 17,640.00 | 5,860.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 4,495.00 | 4,830.00 | 7,830.00 | 5,950.00 | 17,640.00 | 5,860.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |